IL6 and cancer: At the same time, the presence of myeloid-derived suppressor cells (MDSCs), IL-1 and IL-6 expression from cancer cells, M2-polarized tumor-associated macrophages (TAMs), and N2 tumor-associated neutrophils (TANs) are associated with attenuated response to ICI therapy [91].